LEGACY03 - Lymph node flu & COVID-19 vaccine responses in younger or older adults

LEGACY03: Lymph node flu & COVID-19 vaccine responses in younger or older adults

You are invited to take part in a study examining lymph nodes cells to assess immune responses in younger and older adults after immunisation with seasonal influenza vaccine and mRNA COVID-19 vaccine boosters. The study is being led by the Oxford Vaccine Group, which is part of the University of Oxford, and is taking place at the Centre for Clinical Vaccinology and Tropical Medicine at the Churchill Hospital.

If you are either 18 to 45 years old or 65+ years old, in good health and live in the Thames Valley area, then you may be eligible to take part. We will provide £820 total reimbursement amount for your time, inconvenience and travel. The total study participation time is 3 months.

If you would like to find out more, please read the Participant Information Sheet.

If you are interested in joining this study, please visit LEGACY03 Prescreening Questionnaire where you can access the online screening questions and register your interest. 

In addition, if you would like any further information regarding the study, please contact us on:

Email: info@ovg.ox.ac.uk, Tel: 01865 611400

Kind Regards,

The Oxford Vaccine Group